NCT03011125View on ClinicalTrials.gov

A Clinical Trial to Evaluate the Safety and Tolerability of Dexlansoprazole Injection in Healthy Chinese Adults (Part 1)

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

March 9, 2017

Study Completion Date

March 9, 2017

Conditions
Safety Issues
Interventions
DRUG

dexlansoprazole injection

OTHER

placebo

Sponsors
All Listed Sponsors
collaborator

Jiangsu Aosaikang Pharmaceutical Co., Ltd.

INDUSTRY

lead

First Affiliated Hospital of Zhejiang University

OTHER